Jared Gollob
CIK 1821198 · Chief Medical Officer · last filed 2026-03-04
Jared Gollob is a Chief Medical Officer who has filed 28 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for KYMR, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$20.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.00M
1
28
-$20.60M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | Chief Medical Officer | 117,581 | $119.05 | $14.00M | -$20.60M | 18 | 2026-03-04 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | KYMR | Mixed | +7,142 | -$916.7K | EDGAR |
| 2026-03-02 | KYMR | Notice (144) | −10,613 | -$956.2K | EDGAR |
| 2025-12-08 | KYMR | Notice (144) | −49,307 | -$3.28M | EDGAR |
| 2025-12-08 | KYMR | Mixed | — | -$4.11M | EDGAR |
| 2025-10-15 | KYMR | Notice (144) | −59,576 | -$3.47M | EDGAR |
| 2025-10-15 | KYMR | Mixed | −8,367 | -$3.58M | EDGAR |
| 2025-10-14 | KYMR | Notice (144) | −3,114 | -$178.2K | EDGAR |
| 2025-10-14 | KYMR | Mixed | −1,641 | -$184.4K | EDGAR |
| 2025-03-03 | KYMR | Mixed | +24,260 | -$174.8K | EDGAR |
| 2025-03-03 | KYMR | Notice (144) | −5,740 | -$179.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.